MGC Diagnostics

MGC Diagnostics is a global medical technology company that develops, manufactures and markets non-invasive diagnostic systems for the detection, classification and management of cardiorespiratory disease.

In December 2017, Greyrock funded $11.8 million in subordinated debt and equity to support Altus Capital’s purchase of the Company.